New products: Rx, Generics, OTC, HBC Promius Pharma, a wholly-owned subsidiary of Dr.Reddy's Laboratories Inc., has launched EpiCeram Skin Barrier Emulsion, the first prescription medical device cream for the treatment of atopic dermatitis that, in a clinical trial, has...
A Day Late In Oakland prilosec carnitine interaction brush b gone ortho effects of zocor chuck soma long term phentermine use drinking on paroxetine deficient and testosterone marijuana senior citizens medical effects of opium smoking drug generic online pharmacy...
Crab Feed To Raise Funds For Senior Center Owens expects about 150 people to attend the event on November 1, at the South Berkeley Senior Center, 4:30 to 8:30.Tickets are $35.
and going, so people are advised to get their reservation in early.
Call (510) 981-5170.
Funds...
Treating hypertension in the elderly: Expected and unexpected benefits The results of the Hypertension in the Very Elderly Trial (HYVET) are an emphatic endorsement for treating hypertension in very elderly patients.MedWire reporter Eleanor McDermid discussed the findings with lead investigator Professor...
TopAbstracts in Hypertension 09/24/2008 TopAbstracts in Hypertension are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 7 days.Over 2000 peer-reviewed...
Teva Introduces Ramipril Capsules Teva Pharmaceuticals announces the introduction and availability of Ramipril Capsules.Teva Introduces Ramipril Capsules.
FDA Drug Safety Newsletter: Postmarketing Reviews ROCKVILLE, Md., Sept.18, 2008-The FDA today posted on its webiste its Drug Safety Newsletter including items about Mefloquine Hydrochloride (marketed as LARIAM and generics), Lenalidomide (marketed as REVLIMID), Interaction between...
Process for producing solid dosage forms Title: United States Patent: 7,419,685 Inventors: Kothrade; Stephan (Limburgerhof, DE), Berndl; Gunther (Herxheim, DE), Simon; Dirk (Mutterstadt, DE), Sanner; Axel (Frankenthal, DE) Assignee: BASF Aktiengesellschaft (Ludwigshafen, DE) Appl....
Transcend study shows Telmisartan reduces risk associated with CVD Singapore, Sept 15, 2008: The results of the TRANSCEND (Telmisartan Randomised AssessmeNt Study in ACE-iNtolerant subjects with cardiovascular disease CVD) trial demonstrate that Micardis 80mg (telmisartan) reduces the risk of cardiovascular...
TopAbstracts in Hypertension 09/10/2008 TopAbstracts in Hypertension are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 7 days.Over 2000 peer-reviewed...
Team studying drug to delay diabetes onset The Oak Ridger OAK RIDGE, Tenn.Vanderbilt University Medical Center diabetes researchers have launched a study to examine how Ramipril, a commonly prescribed medication for treating high blood pressure, could be a significant tool...
VUMC to research blood pressure medication's effect on Type 2 diabetes The drug, Ramipril, belongs to a class of drugs known as angiotensin converting enzyme (ACE) inhibitors, which are used for treating high blood pressure, heart failure and kidney failure associated with high blood pressure.ACE...
New ONTARGET analysis shows lower not necessarily better when it comes to BP Munich, Germany - A new observational analysis of the ONTARGET study shows that lower is not necessarily better when it comes to blood pressure in this patient population, with coronary heart disease or diabetes plus additional risk factors....
Zydus Cadila gets US FDA nod for Ramipril capsules Zydus Cadila has received an approval from the US FDA to market Ramipril capsules in the strengths of 1.25 mg, 5 mg, and 10 mg.The drug falls in the anit-hypertensive segment.
Zydus Cadila gets US FDA nod for Ramipril ...
New proteomics research from National Taiwan University described - (NewsRx.com) -- Investigators publish new data in the report 'A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit.' According to a study from Taipei, Taiwan, 'In this study, we...
Cadila Gets U.S. FDA Nod for Hypertension Drug Ramipril TherapeuticsDaily.com is free with registration.Created by PharmaLive.com, receive the best of therapeutic news directly into your E-mail box.
Cadila Gets U.S.
FDA Nod for Hypertension Drug Ramipril.
New ONTARGET Analysis Shows Lower Not Necessarily Better When It Comes to BP September 3, 2008 (Munich, Germany) A new observational analysis of the ONTARGET study shows that lower is not necessarily better when it comes to blood pressure in this patient population, with coronary heart disease or diabetes plus...
VUMC to research blood pressure medication's effect on Type 2 diabetes The drug, Ramipril, belongs to a class of drugs known as angiotensin converting enzyme (ACE) inhibitors, which are used for treating high blood pressure, heart failure and kidney failure associated with high blood pressure.ACE...
VUMC to research blood pressure medication's effect on Type 2 diabetes The drug, Ramipril, belongs to a class of drugs known as angiotensin converting enzyme (ACE) inhibitors, which are used for treating high blood pressure, heart failure and kidney failure associated with high blood pressure.ACE...
VUMC to research blood pressure medication's effect on Type 2 diabetes Nashville Business Journal Related News Vandy study: Nurses come on strong about health care in 2008 election [Nashville] Saint Thomas, VUMC land on Thomson Reuters list of top U.S.hospitals [Nashville] Meharry-Vanderbilt Alliance to ...
VUMC to research blood pressure medication's effect on Type 2 diabetes Vanderbilt University Medical Center diabetes researchers have launched a study examining whether a commonly prescribed blood pressure medication for treating high might help prevent or delay the onset of Type 2 diabetes.The drug, ...
Combination Therapy Reduces Proteinuria More Than Single Drugs but causes More Kidney Damage (ONTARGET STUDY) LONDON, Aug.15, 2008--Combination therapy using angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) reduces the levels of excess protein in the urine (proteinuria) more than either therapy alone in...
Lupin net profit jumps by 101%, net sales up by 50% in Q1 Lupin Ltd, the sixth largest pharma company in India with consolidated net sales over Rs 2700 crore in 2007-08, has announced impressive performance during the first quarter ended June 2008 mainly due to launch of Ramipril capsules in...
